SciClone Pharmaceuticals, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (48)

View All

Latest Posts

About This Stock More About This Stock
Week In Review: OrbiMed Raises $800 Million For Its Fourth Asia Fund
Article By: ChinaBio® Today
Saturday, March 6, 2021 12:34 PM EDT
OrbiMed Advisors announced it has secured $3.5 billion in commitments for its latest capital raise, including $800 million for OrbiMed Asia Partners IV. Connect Biopharma of Taicang has filed for a NASDAQ IPO that could raise $100 million.
In this article: AZN, SCLN, GLYC
Read
Week In Review: Week's China Life Science Investments Total $800 Million
Article By: ChinaBio® Today
Saturday, December 19, 2020 12:23 PM EDT
Harbour BioMed completed a $221 million Hong Kong IPO to continue its novel drug development. Singlera Genomics, a San Diego-Shanghai genomics testing company, closed a $150 million Series B financing from China investors.
In this article: HBM, PFE, SCLN, ABBV, ALLO, ADCT, BNTX, LEGN
Read
Week In Review: WuXi Biologics Raises $511 Million In Hong Kong IPO
Article By: ChinaBio® Today
Sunday, June 11, 2017 2:49 AM EDT
WuXi Biologics priced its Hong Kong IPO at the top of the range, raising $511 million and valuing the biologics operations of WuXi AppTec at $3 billion.
In this article: SCLN
Read
Morning Call For March 31, 2016
Article By: Jim Van Meerten
Thursday, March 31, 2016 8:02 AM EDT
June E-mini S&Ps (ESM16 +0.01%) are mildly lower by -0.16% this morning due to a resumed decline in crude oil prices, S&P's cut in its rating outlook for China, and lower European stocks.
In this article: IBM, MDVN, SCLN, AFFX, MU, PRGS, TSLA, WBMD, SUNE, TERP, SQ, GLBL
Read
All Posts

Latest Tweets for $SCLN

No tweets yet!

PARTNER HEADLINES